MedPage Today on MSN

Medicare Prices to Drop Up to 85% on Drugs for Weight-Loss, Cancer, Asthma, and More

The negotiated prices are a result of a program passed by Congress in 2022 as part of the Inflation Reduction Act (IRA). The ...
Drug Store News

Lupin partners with Mark Cuban Cost Plus Drug Company, COPD Foundation to expand medication access

Lupin is partnering with Mark Cuban Cost Plus Drug Company and the COPD Foundation, in an effort to bolster access to health care by expanding the availability of Tiotropium Bromide Inhalation ...
AOL

Can drugs like Ozempic help with COPD?

Researchers estimate the number of people globally living with chronic obstructive pulmonary disease (COPD) will hit 600 million by 2050. There are certain risk factors for COPD, including ...
The American Journal of Managed Care

Various Methods Used in COPD Medication Adherence Assessments, Review Says

The chosen studies featured various methods to assess medication use initiation, implementation, and/or persistence in patients with chronic obstructive pulmonary disease (COPD). The researchers ...
MedCity News

Sanofi & Regeneron Drug Dupixent Gets EMA Approval as the First Biologic COPD Med

Inflammation that develops in chronic obstructive pulmonary disorder stems from different causes. A new regulatory decision in Europe makes Sanofi and Regeneron Pharmaceuticals drug Dupixent the ...
FierceBiotech

With newly discovered cell type, Penn scientists propose COPD drug development strategy

Scientists at the University of Pennsylvania’s Perelman School of Medicine have discovered a new type of cell in human lungs. Reporting in Nature, the scientists named the cells respiratory airway ...